Korean Drug Co., Ltd. (KOSDAQ:014570)

Korean Drug Revenue

Korean Drug had revenue of 14.94B KRW in the quarter ending June 30, 2025, a decrease of -21.25%. This brings the company's revenue in the last twelve months to 62.74B, down -19.48% year-over-year. In the year 2024, Korean Drug had annual revenue of 73.00B, down -10.29%.

• Revenue (ttm): 62.74B
• Revenue Growth: -19.48%
• P/S Ratio: 0.74
• Revenue / Employee: 232.39M
• Employees: 270
• Market Cap: 46.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	73.00B	-8.37B	-10.29%
Dec 31, 2023	81.37B	1.39B	1.74%
Dec 31, 2022	79.98B	5.52B	7.41%
Dec 31, 2021	74.47B	7.68B	11.49%
Dec 31, 2020	66.79B	11.26B	20.28%